Valiant Laboratories Limited (NSE:VALIANTLAB)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Paracetamol Active Pharmaceutical Ingredients/Bulk Drugs	1.82B
Paracetamol Active Pharmaceutical Ingredients/Bulk Drugs Growth	-45.48%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
India	1.81B
India Growth	-45.55%
International	9.37M
International Growth	-28.12%